Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway

Xuejiao Liu^{1

2}, Yiming Tu^{1

3}, Yifeng Wang¹, Di Zhou¹, Yulong Chong⁴, Lin Shi¹, Guanzheng Liu¹, Xu Zhang^{1

2}, Sijin Wu⁵, Huan Li¹, Shangfeng Gao^{1

2}, Mingshan Niu^{1

6}, Rutong Yu^{7

8}

Affiliations

¹ Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
² Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
³ Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
⁴ Department of Neurosurgery, Suqian Hospital Affiliated to Xuzhou Medical University, Suqian, Jiangsu, China.
⁵ College of Pharmacy, The Ohio State University, Columbus, OH, USA.
⁶ Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
⁷ Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China. yu.rutong@163.com.
⁸ Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. yu.rutong@163.com.

Xuejiao Liu et al. Cancer Cell Int. 2024.

. 2024 Sep 18;24(1):320.

doi: 10.1186/s12935-024-03508-w.

¹ Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
² Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
³ Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
⁴ Department of Neurosurgery, Suqian Hospital Affiliated to Xuzhou Medical University, Suqian, Jiangsu, China.
⁵ College of Pharmacy, The Ohio State University, Columbus, OH, USA.
⁶ Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
⁷ Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China. yu.rutong@163.com.
⁸ Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. yu.rutong@163.com.

No abstract available

Retraction of

Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.
Liu X, Tu Y, Wang Y, Zhou D, Chong Y, Shi L, Liu G, Zhang X, Wu S, Li H, Gao S, Niu M, Yu R. Liu X, et al. Cancer Cell Int. 2020 Mar 30;20:97. doi: 10.1186/s12935-020-01186-y. eCollection 2020. Cancer Cell Int. 2020. Retraction in: Cancer Cell Int. 2024 Sep 18;24(1):320. doi: 10.1186/s12935-024-03508-w. PMID: 32256206 Free PMC article. Retracted.

1. Tu Y, Niu M, Xie P, et al. Smoothened is a poor prognosis factor and a potential therapeutic target in glioma. Sci Rep. 2017;7:42630. 10.1038/srep42630. - PMC - PubMed